|
US5175343A
(en)
|
1985-01-14 |
1992-12-29 |
Neorx Corporation |
Metal radionuclide labeled proteins for diagnosis and therapy
|
|
DE3713842A1
(de)
*
|
1987-04-22 |
1988-11-17 |
Schering Ag |
Substituierte cyclische komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
|
|
US4889931A
(en)
|
1988-09-27 |
1989-12-26 |
Salutar, Inc. |
Manganese (II) chelate manufacture
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
WO1990009379A1
(en)
|
1989-02-10 |
1990-08-23 |
Celltech Limited |
Aza-macrocycles and processes for their preparation
|
|
US5053503A
(en)
|
1989-02-17 |
1991-10-01 |
Centocor |
Chelating agents
|
|
US5364613A
(en)
|
1989-04-07 |
1994-11-15 |
Sieving Paul F |
Polychelants containing macrocyclic chelant moieties
|
|
US6274713B1
(en)
|
1989-04-07 |
2001-08-14 |
Salutar, Inc. |
Polychelants
|
|
US7385041B2
(en)
|
1990-04-25 |
2008-06-10 |
Bracco International B.V. |
Dual functioning excipient for metal chelate contrast agents
|
|
ZA914616B
(en)
|
1990-06-18 |
1993-02-24 |
Dow Chemical Co |
The use of macrocyclic aminophosphonic acid complexes as imaging agents
|
|
US5386011A
(en)
|
1990-12-27 |
1995-01-31 |
Abbott Laboratories |
Hexapeptide anaphylatoxin-receptor ligands
|
|
GB9112536D0
(en)
*
|
1991-06-11 |
1991-07-31 |
Celltech Ltd |
Chemical compounds
|
|
JPH07503124A
(ja)
|
1991-06-14 |
1995-04-06 |
ゾーマ・コーポレーション |
微生物によって生産される抗体断片とそれらの複合体
|
|
CA2134239C
(en)
|
1992-06-09 |
2004-11-23 |
Donald B. Axworthy |
Pretargeting methods and compounds
|
|
US5358704A
(en)
|
1993-09-30 |
1994-10-25 |
Bristol-Myers Squibb |
Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents
|
|
GB9504922D0
(en)
|
1995-03-10 |
1995-04-26 |
Nycomed As |
Process
|
|
JP3876002B2
(ja)
|
1997-04-14 |
2007-01-31 |
ミクロメート・アクチエンゲゼルシャフト |
抗ヒト抗原受容体を産生するための斬新な方法およびそれらの使用
|
|
IT1291624B1
(it)
|
1997-04-18 |
1999-01-11 |
Bracco Spa |
Chelati complessi di metalli paramagnetici a bassa tossicita'
|
|
IT1304501B1
(it)
|
1998-12-23 |
2001-03-19 |
Bracco Spa |
Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
|
|
WO2000076556A2
(en)
|
1999-06-11 |
2000-12-21 |
Neorx Corporation |
High dose radionuclide complexes for bone marrow suppression
|
|
US6887842B1
(en)
*
|
1999-11-19 |
2005-05-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug
|
|
DE10002939C1
(de)
|
2000-01-13 |
2001-09-20 |
Schering Ag |
Paramagnetische DOTA-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für die Herstellung von pharmazeutischen Mitteln
|
|
US20020052354A1
(en)
|
2000-01-27 |
2002-05-02 |
Schering Ag |
Paramagnetic DOTA derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction
|
|
US6264966B1
(en)
|
2000-02-22 |
2001-07-24 |
Concat, Ltd. |
Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
|
|
AU7748801A
(en)
|
2000-05-12 |
2002-04-02 |
Mallinckrodt Inc |
Prochelators for the preparation of radiometal labeled molecules having improvedbiological properties
|
|
JP2004536034A
(ja)
|
2001-01-08 |
2004-12-02 |
ネオルクス コーポレイション |
治療的および診断的化合物、組成物および方法
|
|
DE10135355C1
(de)
|
2001-07-20 |
2003-04-17 |
Schering Ag |
Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie
|
|
DE10135356C1
(de)
|
2001-07-20 |
2003-04-17 |
Schering Ag |
Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
|
|
TWI284539B
(en)
|
2001-07-30 |
2007-08-01 |
Epix Pharm Inc |
A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide
|
|
JP2005534697A
(ja)
|
2002-08-06 |
2005-11-17 |
エピックス ファーマシューティカルズ， インコーポレイテッド |
ペプチド凝集体
|
|
DE10250870A1
(de)
|
2002-10-31 |
2004-05-13 |
Switch Biotech Ag |
Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung
|
|
US20060235296A1
(en)
|
2003-02-13 |
2006-10-19 |
Bracco Imaging S.P.A. |
Contrast enhanced x-ray phase imaging
|
|
DK1603598T3
(da)
|
2003-03-19 |
2009-01-26 |
Univ Bern |
Radiomærkede konjugater baseret på substans P og anvendelser heraf
|
|
CA2526760A1
(en)
|
2003-05-23 |
2005-01-06 |
Epix Pharmaceuticals, Inc. |
Optically pure and enriched isomers of chelating ligands and contrast agents
|
|
JP4262545B2
(ja)
|
2003-07-09 |
2009-05-13 |
三菱電機株式会社 |
カスコード接続回路及びその集積回路
|
|
DE602004025592D1
(de)
|
2003-09-12 |
2010-04-01 |
Life Technologies Corp |
Anwendungen des Resonanzenergietransfers zwischen Terbium und GFP
|
|
CA2550071A1
(en)
|
2003-12-19 |
2005-07-07 |
Schering Corporation |
Pharmaceutical compositions
|
|
WO2005079803A1
(en)
|
2004-02-13 |
2005-09-01 |
Pfizer Products, Inc. |
Compounds for treatment of cardiovascular diseases
|
|
WO2006015318A2
(en)
|
2004-07-30 |
2006-02-09 |
Biogen Idec Inc. |
Antibody conjugated to a drug moiety via a poptidic linker
|
|
TR201808537T4
(tr)
|
2004-09-23 |
2018-07-23 |
Genentech Inc |
Sistein değiştirilmiş antikorlar ve konjugatlar.
|
|
US20060222595A1
(en)
|
2005-03-31 |
2006-10-05 |
Priyabrata Mukherjee |
Nanoparticles for therapeutic and diagnostic applications
|
|
WO2007009637A2
(de)
|
2005-07-15 |
2007-01-25 |
Bayer Schering Pharma Aktiengesellschaft |
Deren verwendung als kontrastmittel zur anwendung in der nmr-, rontgen- und radiodiagnostik sowie in der radiotheraphie
|
|
US7618957B2
(en)
|
2005-07-15 |
2009-11-17 |
Bayer Schering Pharma Aktiengesellschaft |
Perfluoroalkyl-containing complexes, process for their production as well as their use
|
|
US20100226884A1
(en)
*
|
2009-01-20 |
2010-09-09 |
Immunomedics, Inc. |
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
|
|
US8034898B2
(en)
|
2005-12-29 |
2011-10-11 |
Collagen Medical, LLC |
Methods of collagen imaging
|
|
US20090053137A1
(en)
|
2006-03-15 |
2009-02-26 |
Moore Dennis A |
Chelating Conjugates Having a Substituted Aromatic Moiety and Derivatives Thereof
|
|
US7777029B2
(en)
|
2006-05-02 |
2010-08-17 |
San Diego State University (Sdsu) Foundation |
Bifunctional chelators for sequestering lanthanides
|
|
EP2061884A4
(en)
|
2006-08-11 |
2010-03-24 |
Life Technologies Corp |
SENSOR PROTEINS AND TEST PROCEDURES THEREFOR
|
|
US8691761B2
(en)
*
|
2006-10-16 |
2014-04-08 |
Jean E. F. Rivier |
Somatostatin receptor 2 antagonists
|
|
GB0624587D0
(en)
|
2006-12-08 |
2007-01-17 |
Univ Muenchen Tech |
Chelating agent
|
|
CN101626787A
(zh)
|
2007-01-19 |
2010-01-13 |
马林克罗特公司 |
诊断的和治疗的环氧合酶-2结合配体
|
|
WO2008134289A2
(en)
|
2007-04-26 |
2008-11-06 |
Mallinckrodt Inc. |
High relaxivity coordinatively unsaturated lanthanide complexes
|
|
US20090053245A1
(en)
*
|
2007-05-29 |
2009-02-26 |
Mutz Mitchell W |
Pharmacokinetics and Efficacy of Anti-Angiogenic Drugs and Drugs Treating Diseases of the Blood
|
|
US8420857B2
(en)
|
2007-08-27 |
2013-04-16 |
Mallinckrodt Llc |
Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography
|
|
JP2010537985A
(ja)
|
2007-08-28 |
2010-12-09 |
バイオジェン アイデック マサチューセッツ インコーポレイテッド |
抗ｉｇｆ−１ｒ抗体およびその使用
|
|
US20090208421A1
(en)
|
2008-02-19 |
2009-08-20 |
Dominique Meyer |
Process for preparing a pharmaceutical formulation of contrast agents
|
|
DE102008045937B4
(de)
|
2008-04-11 |
2017-01-26 |
Johannes-Gutenberg-Universität Mainz |
Radiopharmakon aus einem Metallion und einem Markierungsvorläufer und Verwendung des Radiopharmakons
|
|
WO2010009246A2
(en)
|
2008-07-16 |
2010-01-21 |
The General Hospital Corporation |
Methods and reagents for preparing multifunctional probes
|
|
EP2147684A1
(en)
|
2008-07-22 |
2010-01-27 |
Bracco Imaging S.p.A |
Diagnostic Agents Selective Against Metalloproteases
|
|
CN102271713B
(zh)
|
2008-11-06 |
2013-07-31 |
路易莎·布拉奇 |
神经降压肽衍生的分枝肽及其用途
|
|
WO2010088527A2
(en)
|
2009-01-30 |
2010-08-05 |
Mayo Foundation For Medical Education And Research |
Peptides and nanoparticles for therapeutic and diagnostic applications
|
|
BRPI1009900A2
(pt)
|
2009-03-19 |
2016-03-15 |
Wyeth Llc |
métodos para a preparação de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfônico e seus precursores
|
|
WO2011005609A2
(en)
|
2009-07-08 |
2011-01-13 |
Mayo Foundation For Medical Education And Research |
Imaging gastrointestinal volumes and motility
|
|
EP2515914A4
(en)
|
2009-12-23 |
2013-09-11 |
Scripps Research Inst |
BIOCONJUGATION OF TYROSINE BY EYE REACTIONS IN AQUEOUS MEDIA
|
|
IN2012DN05101A
(enExample)
|
2010-01-19 |
2015-10-23 |
Immunomedics Inc |
|
|
EP2397466B1
(en)
|
2010-06-15 |
2012-11-28 |
Centre National De La Recherche Scientifique CNRS |
X-ray and gamma-photon activatable organic compounds, their preparation and their uses
|
|
CN103153330B
(zh)
|
2010-08-12 |
2017-08-18 |
美国科技环球有限公司 |
新的环孢霉素衍生物在病毒感染的治疗和预防中的应用
|
|
US12097269B2
(en)
|
2010-10-27 |
2024-09-24 |
Vikas Kundra |
Dual mode gadolinium nanoparticle contrast agents
|
|
FR2968999B1
(fr)
|
2010-12-20 |
2013-01-04 |
Guerbet Sa |
Nanoemulsion de chelate pour irm
|
|
US20140088019A1
(en)
|
2011-02-11 |
2014-03-27 |
Zyngenia, Inc. |
Monovalent and Multivalent Multispecific Complexes and Uses Thereof
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
WO2012177701A2
(en)
|
2011-06-20 |
2012-12-27 |
Radiomedix Inc. |
Compositions, methods of synthesis and use of carbohydrate targeted agents
|
|
FR2976825B1
(fr)
|
2011-06-22 |
2014-02-21 |
Total Sa |
Nanotraceurs pour le marquage d'eaux d'injection de champs petroliers
|
|
EP2604281B1
(en)
|
2011-12-14 |
2014-07-30 |
Centre National de la Recherche Scientifique (CNRS) |
Clicked somatostatin conjugated analogs for biological applications
|
|
KR20130083592A
(ko)
|
2012-01-13 |
2013-07-23 |
현대약품 주식회사 |
치환된 피페리딘 유도체 및 이의 제조방법
|
|
EP2852685A1
(en)
|
2012-03-30 |
2015-04-01 |
Merck Sharp & Dohme Corp. |
Igf1 biomarker for igf1r inhibitor therapy
|
|
RU2015100900A
(ru)
|
2012-06-14 |
2016-08-10 |
Янссен Байотек, Инк. |
Обработка плюрипотентных клеток
|
|
CN102743770B
(zh)
|
2012-06-18 |
2017-07-21 |
申宝忠 |
一种靶向性分子成像探针及活体分子成像方法
|
|
CN104602715A
(zh)
|
2012-09-07 |
2015-05-06 |
伯拉考成像股份公司 |
用于MRI的包含金属两亲配合物的顺磁性固体脂质纳米颗粒(pSLN)
|
|
US9931412B2
(en)
|
2013-02-08 |
2018-04-03 |
The Regents Of The University Of Michigan |
Targeted theranostics
|
|
EP2994471B1
(en)
|
2013-05-06 |
2017-05-17 |
Merck Patent GmbH |
Macrocycles as kinase inhibitors
|
|
WO2015023979A1
(en)
|
2013-08-16 |
2015-02-19 |
Equip, Llc |
Discrete peg constructs
|
|
US10471163B2
(en)
|
2013-09-13 |
2019-11-12 |
The General Hospital Corporation |
Activatable fibrin-binding probes
|
|
AU2014336638C1
(en)
|
2013-10-18 |
2020-09-17 |
Novartis Ag |
Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
US10758636B2
(en)
*
|
2013-11-12 |
2020-09-01 |
Centre For Probe Development And Commercialization |
Residualizing linkers and uses thereof
|
|
US20170050989A1
(en)
|
2013-12-03 |
2017-02-23 |
The General Hospital Corporation |
Molecular Imaging Probes
|
|
FR3015547B1
(fr)
|
2013-12-20 |
2016-01-01 |
Total Sa |
Methode pour ajuster le taux d'inhibiteurs dans un puits de petrole ou de gaz
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
ES2719584T3
(es)
|
2014-04-11 |
2019-07-11 |
Medimmune Llc |
Compuestos conjugados que comprenden anticuerpos modificados por ingeniería genética con cisteína
|
|
KR20190072663A
(ko)
|
2014-04-25 |
2019-06-25 |
리나트 뉴로사이언스 코프. |
약물이 고도로 로딩된 항체-약물 접합체
|
|
US11660357B2
(en)
*
|
2014-05-16 |
2023-05-30 |
David A. Scheinberg |
One-step labeling of antibodies to high specific activity with actinium-225
|
|
WO2016016329A1
(en)
|
2014-07-29 |
2016-02-04 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
|
BE1021191B1
(fr)
|
2014-08-29 |
2015-10-27 |
Anmi S.A. |
Kit pour radiomarquage.
|
|
GB201417067D0
(en)
|
2014-09-26 |
2014-11-12 |
South African Nuclear Energy |
Radiopharmaceutical conjugate
|
|
DE102014115154A1
(de)
|
2014-10-17 |
2016-04-21 |
SCV-SpezialChemikalien-Vertrieb GmbH |
Konjugierte Bisphosphonate für die Diagnostik und Therapie von Knochenerkrankungen
|
|
JP6622814B2
(ja)
|
2014-11-25 |
2019-12-18 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
イメージングのための新規ｐｄ−ｌ１結合ポリペプチド
|
|
WO2017120193A1
(en)
*
|
2016-01-04 |
2017-07-13 |
University Of Kansas |
Drug delivery compositions and methods
|
|
US10758634B2
(en)
*
|
2016-03-18 |
2020-09-01 |
Wake Forest University |
Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
|
|
CN118368739A
(zh)
*
|
2017-03-24 |
2024-07-19 |
中兴通讯股份有限公司 |
一种无线资源配置方法、装置及用户设备、网络节点
|
|
AU2018261888B2
(en)
|
2017-05-05 |
2022-06-30 |
Centre For Probe Development And Commercialization |
Pharmacokinetic enhancements of bifunctional chelates and uses thereof
|
|
WO2018204872A2
(en)
|
2017-05-05 |
2018-11-08 |
Fusion Pharmaceuticals Inc. |
Igf-1r monoclonal antibodies and uses thereof
|
|
US10093741B1
(en)
*
|
2017-05-05 |
2018-10-09 |
Fusion Pharmaceuticals Inc. |
IGF-1R monoclonal antibodies and uses thereof
|